Microbiology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.
Hematology Service, Hospital Clínico Universitario, Institute for Research INCLIVA, Valencia, Spain.
Med Microbiol Immunol. 2019 Apr;208(2):253-258. doi: 10.1007/s00430-019-00586-w. Epub 2019 Mar 9.
Torque teno virus (TTV) plasma DNA load has been consistently shown to be a surrogate biomarker of immunosuppression in solid organ transplant recipients. It is uncertain whether it may behave similarly in allogeneic hematopoietic stem cell transplant recipients (allo-HSCT). Here, we characterized the dynamics of TTV DNAemia in patients undergoing T-cell replete allo-SCT at late times after transplantation (> day + 100). This retrospective single-center observational study included 33 allo-HSCT patients. Plasma TTV DNA loads were quantified by real-time PCR before initiating the conditioning regimen and at different time points after transplant. Absolute lymphocyte counts (ALC) were measured by flow cytometry. Overall, TTV DNA load increased steadily after engraftment, reaching a peak by day + 90; afterwards, it remained relatively constant until day + 210. TTV DNA loads measured within days + 120 and + 210 correlated inversely with paired ALC, while both parameters did correlate directly within days + 20 and + 60. The median TTV DNA area under a curve between days + 90 and + 210 [(AUC)] was significantly higher in patients who received corticosteroids within this time frame for treatment of graft versus host disease (either acute, chronic or both) than in controls (P = 0.025). In summary, TTV DNA load may mirror the degree of immunosuppression at late times after allo-HSCT.
Torque teno 病毒 (TTV) 血浆 DNA 载量一直被证明是实体器官移植受者免疫抑制的替代生物标志物。它在异基因造血干细胞移植受者(allo-HSCT)中的表现是否相似尚不确定。在这里,我们在移植后晚期(>100 天)对接受 T 细胞充足的 allo-SCT 的患者进行了 TTV DNA 血症的动力学特征分析。这项回顾性单中心观察性研究纳入了 33 例 allo-HSCT 患者。在开始预处理方案之前和移植后不同时间点通过实时 PCR 定量检测血浆 TTV DNA 载量。通过流式细胞术测量绝对淋巴细胞计数(ALC)。总体而言,TTV DNA 载量在植入后稳步增加,在第+90 天达到峰值;此后,它在第+210 天之前相对保持稳定。在第+120 天和第+210 天测量的 TTV DNA 载量与配对的 ALC 呈负相关,而这两个参数在第+20 天和第+60 天内呈直接相关。在这一时间段内因移植物抗宿主病(急性、慢性或两者兼有)而接受皮质类固醇治疗的患者的第+90 天至第+210 天 TTV DNA 曲线下面积(AUC)中位数明显高于对照组(P=0.025)。总之,TTV DNA 载量可能反映 allo-HSCT 后晚期免疫抑制的程度。